CoChat

Thiazolidinediones but Not Metformin Directly Inhibit the Steroidogenic Enzymes P450c17 and 3β-Hydroxysteroid Dehydrogenase

Open access
Arlt, Wiebke, Auchus, Richard J., Miller, Walter L. · 2001 · Journal of Biological Chemistry

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Androgen biosynthesis requires 3beta-hydroxysteroid dehydrogenase type II (3betaHSDII) and the 17alpha-hydroxylase and 17,20-lyase activities of cytochrome P450c17. Thiazolidinedione and biguanide drugs, which are used to increase insulin sensitivity in type 2 diabetes, lower serum androgen concentrations in women with polycystic ovary syndrome. However, it is unclear whether this is secondary to increased insulin sensitivity or to direct effects on steroidogenesis. To investigate potential actions of these drugs on P450c17 and 3betaHSDII, we used "humanized yeast" that express these steroidogenic enzymes in microsomal environments. The biguanide metformin had no effect on either enzyme, whereas the thiazolidinedione troglitazone inhibited 3betaHSDII (K(I) = 25.4 +/- 5.1 microm) and both activities of P450c17 (K(I) for 17alpha-hydroxylase, 8.4 +/- 0.6 microm; K(I) for 17,20-lyase, 5.3 +/- 0.7 microm). The action of troglitazone on P450c17 was competitive, but it was mainly a noncompetitive inhibitor of 3betaHSDII. The thiazolidinediones rosiglitazone and pioglitazone exerted direct but weaker inhibitory effects on both P450c17 and 3betaHSDII. These differential effects of the thiazolidinediones do not correlate with their effects on insulin sensitivity, suggesting that distinct regions of the thiazolidinedione molecule mediate these two actions. Thus, thiazolidinediones inhibit two key enzymes in human androgen synthesis contributing to their androgen-lowering effects, whereas metformin affects androgen synthesis indirectly, probably by lowering circulating insulin concentrations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m100040200

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1 Structures and chemical reactions. A , only two enzymes are needed to catalyze the steroid biosynthetic reactions shown, P450c17 and 3 b HSDII. The 17 a -hydroxylase activity of P450c17 catalyzes the conversion of pregnenolone to 17-Preg and of progesterone to 17OHP with equivalent Km and V max values (8); the 17,20-lyase activity of P450c17 catalyzes the conversion of 17-Preg to DHEA with much lower efficiency (8). 3 b HSDII converts pregnenolone to progesterone, 17-Preg to 17OHP, and DHEA to androstenedione, all with equivalent Km and V max values (21). In this study, 3 b HSD activity is measured as conversion of pregnenolone to progesterone, 17 a -hydroxylase activity is measured as conversion of progesterone to 17OHP, and 17,20-lyase activity is measured as conversion of 17-Preg to DHEA. B , structures of the inhibitors used. Top , metformin, shown as the hydrochloride; middle , the thiazolidinedione nucleus (note the R group in the ether linkage); bottom , structures of the thiazolidinedione R group in troglitazone ( TRO ), rosiglitazone ( ROSI ), and pioglitazone ( PIO ).
FIG. 1 Structures and chemical reactions. A , only two enzymes are needed to catalyze the steroid biosynthetic reactions shown, P450c17 and 3 b HSDII. The 17 a -hydroxylase activity of P450c17 catalyzes the conversion of pregnenolone to 17-Preg and of progesterone to 17OHP with equivalent Km and V max values (8); the 17,20-lyase activity of P450c17 catalyzes the conversion of 17-Preg to DHEA with much lower efficiency (8). 3 b HSDII converts pregnenolone to progesterone, 17-Preg to 17OHP, and DHEA to androstenedione, all with equivalent Km and V max values (21). In this study, 3 b HSD activity is measured as conversion of pregnenolone to progesterone, 17 a -hydroxylase activity is measured as conversion of progesterone to 17OHP, and 17,20-lyase activity is measured as conversion of 17-Preg to DHEA. B , structures of the inhibitors used. Top , metformin, shown as the hydrochloride; middle , the thiazolidinedione nucleus (note the R group in the ether linkage); bottom , structures of the thiazolidinedione R group in troglitazone ( TRO ), rosiglitazone ( ROSI ), and pioglitazone ( PIO ).CC-BY · From the PDF
FIG. 2 Effect of metformin and troglitazone on the differential activities of human P450c17. A , 17 a -hydroxylase activity. Microsomes prepared from yeast coexpressing human P450c17 and human P450 oxidoreductase were incubated with 1 m M [ 14 C]progesterone ( Prog ) and 0-100 m M metformin ( MET ) and troglitazone ( TRO ). 17 a -Hydroxylase activity was assessed as the conversion rate of [ 14 C]progesterone to 17OHP. B , 17,20-lyase activity. Microsomes coexpressing P450c17 and OR were incubated with 1 m M 17-Preg and 0-100 m M metformin and troglitazone. 17,20-Lyase activity was assessed as the conversion rate of [ 3 H]17 a -hydroxypregnenolone to DHEA. Each data point represents the mean 6 S.D. of triplicate determinations.
FIG. 2 Effect of metformin and troglitazone on the differential activities of human P450c17. A , 17 a -hydroxylase activity. Microsomes prepared from yeast coexpressing human P450c17 and human P450 oxidoreductase were incubated with 1 m M [ 14 C]progesterone ( Prog ) and 0-100 m M metformin ( MET ) and troglitazone ( TRO ). 17 a -Hydroxylase activity was assessed as the conversion rate of [ 14 C]progesterone to 17OHP. B , 17,20-lyase activity. Microsomes coexpressing P450c17 and OR were incubated with 1 m M 17-Preg and 0-100 m M metformin and troglitazone. 17,20-Lyase activity was assessed as the conversion rate of [ 3 H]17 a -hydroxypregnenolone to DHEA. Each data point represents the mean 6 S.D. of triplicate determinations.CC-BY · From the PDF
FIG. 3 Kinetic analysis of the mode of inhibition of P450c17 activities by troglitazone ( TRO ). Lineweaver-Burk plots of 17 a -hydroxylase activity ( A ) and 17,20-lyase activity ( B ) and Dixon plot of 17 a -hydroxylase activity ( C ) in the absence and presence of troglitazone (0-20 m M) and with 0.5, 1, 2, and 4 m M [ 14 C]progesterone ( Prog ) and 17-Preg for the assessment of 17 a -hydroxylase and 17,20-lyase activity, respectively. Incubations were carried out with yeast microsomes (40 m g of total protein) coexpressing human P450c17 and human P450 oxidoreductase. Each data point represents the mean 6 S.D. of triplicate determinations.
FIG. 3 Kinetic analysis of the mode of inhibition of P450c17 activities by troglitazone ( TRO ). Lineweaver-Burk plots of 17 a -hydroxylase activity ( A ) and 17,20-lyase activity ( B ) and Dixon plot of 17 a -hydroxylase activity ( C ) in the absence and presence of troglitazone (0-20 m M) and with 0.5, 1, 2, and 4 m M [ 14 C]progesterone ( Prog ) and 17-Preg for the assessment of 17 a -hydroxylase and 17,20-lyase activity, respectively. Incubations were carried out with yeast microsomes (40 m g of total protein) coexpressing human P450c17 and human P450 oxidoreductase. Each data point represents the mean 6 S.D. of triplicate determinations.CC-BY · From the PDF
FIG. 4 Inhibition of 17 a -hydroxylase activity by troglitazone ( TRO ) in whole cells ( solid line ) and in yeast microsomes ( dotted line ). COS-1 cells transiently expressing human P450c17 and yeast microsomes expressing both P450c17 and P450 oxidoreductase were incubated with [ 14 C]progesterone ( Prog ), and 17 a -hydroxylase activity was determined as the conversion rate of [ 14 C]progesterone to 17OHP. Each data point represents the mean 6 S.D. of triplicate determinations.
FIG. 4 Inhibition of 17 a -hydroxylase activity by troglitazone ( TRO ) in whole cells ( solid line ) and in yeast microsomes ( dotted line ). COS-1 cells transiently expressing human P450c17 and yeast microsomes expressing both P450c17 and P450 oxidoreductase were incubated with [ 14 C]progesterone ( Prog ), and 17 a -hydroxylase activity was determined as the conversion rate of [ 14 C]progesterone to 17OHP. Each data point represents the mean 6 S.D. of triplicate determinations.CC-BY · From the PDF
Image 5
CC-BY · From the PDF
Image 6
CC-BY · From the PDF
FIG. 6 Kinetic analysis of the mode of inhibition of 3 b HSDII activity by troglitazone ( TRO ). Lineweaver-Burk plot ( A ) and Dixon plot ( B ) of 3 b HSDII activity. Incubations were carried out with yeast microsomes (40 m g total protein) expressing human 3 b HSDII in the absence and presence of troglitazone (0-60 m M) with 1, 5, 10, and 20 m M [ 14 C]pregnenolone ( Preg ). Each data point represents the mean 6 S.D. of triplicate determinations.
FIG. 6 Kinetic analysis of the mode of inhibition of 3 b HSDII activity by troglitazone ( TRO ). Lineweaver-Burk plot ( A ) and Dixon plot ( B ) of 3 b HSDII activity. Incubations were carried out with yeast microsomes (40 m g total protein) expressing human 3 b HSDII in the absence and presence of troglitazone (0-60 m M) with 1, 5, 10, and 20 m M [ 14 C]pregnenolone ( Preg ). Each data point represents the mean 6 S.D. of triplicate determinations.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 11

  1. Penning, 1997, Endocr. Rev., 18, 281
  2. Simpson, 1994, Endocr. Rev., 15, 342
  3. Lin, 1993, Endocrinology, 132, 2498, 10.1210/endo.132.6.8504753 · doi:10.1210/endo.132.6.8504753 · Paper page
  4. Dunaif, 1997, Endocr. Rev., 18, 774
  5. Dunaif, 1996, J. Clin. Endocrinol. Metab., 81, 3299
  6. Ehrmann, 1997, J. Clin. Endocrinol. Metab., 82, 2108
  7. Lee, 1999, J. Clin. Endocrinol. Metab., 84, 2104
  8. Nestler, 1997, J. Clin. Endocrinol. Metab., 82, 4075
  9. Crave, 1995, J. Clin. Endocrinol. Metab., 80, 2057
  10. Maeshiba, 1997, Arzneim. Forsch., 47, 29
  11. Cox, 2000, Drug Metab. Dispos., 28, 772

Cited by

See all 157

Metadata

Authors
Arlt, W., Auchus, R. J., & Miller, W. L.
Affiliations
  • University of California, San Francisco (US)
  • The University of Texas Southwestern Medical Center (US)
Corresponding author
Miller, Walter L.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2001-05
Volume
276
Issue
20
Pages
16767-16771
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2050353370
Cited by
157
References
42
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 7 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 5 · 2014: 3 · 2013: 7 · 2012: 7
FWCI
12.52
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Deutsche Forschungsgemeinschaft
  • National Institutes of Health (5k08dk002387-06)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K08 DK 02387, R01DK037922, R01DK37922)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54-HD34449, U54HD034449)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
thiazolidinediones, metformin, P450c17, steroidogenesis, androgen production, troglitazone, rosiglitazone, pioglitazone, polycystic ovary syndrome, enzyme inhibition, insulin sensitivity, type 2 diabetes
MeSH terms
Pioglitazone, Troglitazone, Biguanides, Chromans, Cloning, Molecular, Humans, Kinetics, Metformin, Recombinant Proteins, Saccharomyces cerevisiae, Steroid Hydroxylases, Steroid 17-alpha-Hydroxylase, Thiazoles, 3-Hydroxysteroid Dehydrogenases, Thiazolidinediones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thiazolidinediones but Not Metformin Directly Inhibit the Steroidogenic Enzymes P450c17 and 3β-Hydroxysteroid Dehydrogenase. https://app.cochat.ai/papers/10.1074/jbc.m100040200
The paper
Arlt, W., Auchus, R. J., & Miller, W. L. (2001). Thiazolidinediones but Not Metformin Directly Inhibit the Steroidogenic Enzymes P450c17 and 3β-Hydroxysteroid Dehydrogenase. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m100040200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.